BL Pharmtech Corp. (KOSDAQ:065170)

BL Pharmtech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24,495	20,819	44,929	55,605	116,549	145,716
Market Cap Growth	-27.38%	-53.66%	-19.20%	-52.29%	-20.02%	65.77%
Enterprise Value	27,055	25,570	86,785	100,284	144,445	185,313
Last Close Price	918.00	780.00	1683.33	2083.33	4366.67	5583.33
PS Ratio	2.94	2.36	1.83	2.47	1.38	2.22
PB Ratio	1.06	0.86	1.41	1.35	1.78	2.00
P/TBV Ratio	1.07	0.87	1.46	2.26	2.66	4.13
P/FCF Ratio	19.40	-	5.85	-	46.44	-
P/OCF Ratio	18.41	-	5.62	-	37.64	25.11
EV/Sales Ratio	3.25	2.90	3.54	4.45	1.71	2.82
EV/EBITDA Ratio	-	-	-	-	-	394.74
EV/FCF Ratio	21.42	-	11.30	-	57.56	-
Debt / Equity Ratio	0.27	0.25	0.13	1.04	0.64	0.60
Debt / EBITDA Ratio	-	-	-	-	-	93.61
Debt / FCF Ratio	4.88	-	0.56	-	16.69	-
Asset Turnover	0.21	0.22	0.33	0.19	0.64	0.59
Inventory Turnover	2.37	1.64	1.32	0.87	6.68	5.12
Quick Ratio	0.45	0.73	1.79	0.34	0.90	0.71
Current Ratio	0.83	1.05	2.12	0.67	1.14	1.09
Return on Equity (ROE)	-20.19%	-20.39%	-37.90%	-27.09%	-29.05%	-26.79%
Return on Assets (ROA)	-6.29%	-6.68%	-5.99%	-2.56%	-1.70%	-1.15%
Return on Capital (ROIC)	-7.66%	-8.18%	-7.42%	-3.13%	-2.00%	-1.31%
Earnings Yield	-22.40%	-27.41%	-0.33%	-25.00%	-17.34%	-12.32%
FCF Yield	5.16%	-20.19%	17.09%	-22.85%	2.15%	-8.11%
Buyback Yield / Dilution	0.52%	-	0.00%	-1.33%	-18.44%	-19.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.